For the active immunization of pigs over the age of two weeks against porcine circovirus type 2 to reduce viremia, fecal shedding and lymphoid lesions.
20ml ×300bottle
100ml×60bottle
China Veterinary Drug Biological Product Approval No. :160021069
ACTIVE SUBSTANCE:Porcine Circovirus Type 2 virus, Strain SH (Before inactivation≥1.0*106.0 TCID50 /ml )
PHARMACEUTICAL FORM Pinkish emulsion for injection
Efficacy for at least 12 weeks following completion of vaccination has been demonstrated.
Feature
Initiate in China and establishment a new standard for inactivated circovirus vaccine
Leading Process ——PKK clone cells tidal microcarrier suspension culture
Ensure the P50 generation still maintains the high sensitivity to PCV2
The use of tidal micro-carrier suspension culture.
Stable quality——Optimization and upgrading of cloning technology
Deep purification of PCV2 antigen, removal of BSA from serum, reduction of heterologous proteins, and elimination of tramp protein and cell debris from semi-finished products, making the antigen content more stable.
Adjuvant upgrade - safer, more efficient, and longer lasting
Biphasic compound adjuvant (W/OW) can better stimulate humoral immunity and cellular immunity, which can make antibody protection more comprehensive, herd healthier and more effective while releasing quickly and taking effect after immunization.
Immune enhancement - Billion level market clinical verification
The clinical application of hundred million pigs once again proves that Yuanjian can significantly reduce the production cost and improve the economic efficiency of pig farms.
Recommended immunization program
Good feeding management and advacned immunization program are the basis for preventing and controlling circovirus-related diseases and improving production performance and pig raising efficiency. We suggest that sow and piglets can be immunized together, the effect is more obvious, and the prevention and control is more thorough.